BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23186131)

  • 1. Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Coffin PO; Santos GM; Das M; Santos DM; Huffaker S; Matheson T; Gasper J; Vittinghoff E; Colfax GN
    Addiction; 2013 Apr; 108(4):751-61. PubMed ID: 23186131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine to reduce methamphetamine use: a randomized controlled trial.
    Colfax GN; Santos GM; Das M; Santos DM; Matheson T; Gasper J; Shoptaw S; Vittinghoff E
    Arch Gen Psychiatry; 2011 Nov; 68(11):1168-75. PubMed ID: 22065532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.
    Coffin PO; Santos GM; Hern J; Vittinghoff E; Santos D; Matheson T; Colfax G; Batki SL
    Addiction; 2018 Feb; 113(2):268-278. PubMed ID: 28734107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial.
    Coffin PO; Santos GM; Hern J; Vittinghoff E; Walker JE; Matheson T; Santos D; Colfax G; Batki SL
    JAMA Psychiatry; 2020 Mar; 77(3):246-255. PubMed ID: 31825466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis.
    Sulaiman AH; Gill JS; Said MA; Zainal NZ; Hussein HM; Guan NC
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):131-8. PubMed ID: 22486597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men.
    Das M; Santos D; Matheson T; Santos GM; Chu P; Vittinghoff E; Shoptaw S; Colfax GN
    AIDS; 2010 Apr; 24(7):991-1000. PubMed ID: 20397286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
    Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence.
    Tiihonen J; Kuoppasalmi K; Föhr J; Tuomola P; Kuikanmäki O; Vorma H; Sokero P; Haukka J; Meririnne E
    Am J Psychiatry; 2007 Jan; 164(1):160-2. PubMed ID: 17202560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial.
    Elkashef A; Kahn R; Yu E; Iturriaga E; Li SH; Anderson A; Chiang N; Ait-Daoud N; Weiss D; McSherry F; Serpi T; Rawson R; Hrymoc M; Weis D; McCann M; Pham T; Stock C; Dickinson R; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Li MD; Johnson BA
    Addiction; 2012 Jul; 107(7):1297-306. PubMed ID: 22221594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
    J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder.
    Findling RL; Youngstrom EA; McNamara NK; Stansbrey RJ; Wynbrandt JL; Adegbite C; Rowles BM; Demeter CA; Frazier TW; Calabrese JR
    J Clin Psychiatry; 2012 Jan; 73(1):57-63. PubMed ID: 22152402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence.
    Brensilver M; Heinzerling KG; Swanson AN; Shoptaw SJ
    Exp Clin Psychopharmacol; 2012 Oct; 20(5):430-5. PubMed ID: 22867036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil for the treatment of methamphetamine dependence.
    Anderson AL; Li SH; Biswas K; McSherry F; Holmes T; Iturriaga E; Kahn R; Chiang N; Beresford T; Campbell J; Haning W; Mawhinney J; McCann M; Rawson R; Stock C; Weis D; Yu E; Elkashef AM
    Drug Alcohol Depend; 2012 Jan; 120(1-3):135-41. PubMed ID: 21840138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
    Keck PE; Calabrese JR; McIntyre RS; McQuade RD; Carson WH; Eudicone JM; Carlson BX; Marcus RN; Sanchez R;
    J Clin Psychiatry; 2007 Oct; 68(10):1480-91. PubMed ID: 17960961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.